Replimune Group, Inc

Replimune Inc, based in Woburn, is at the forefront of developing a groundbreaking category of tumor-targeted oncolytic immunotherapies. Their innovative treatments aim to achieve remarkable outcomes for challenging cancer types, offering new hope for patients facing difficult-to-treat malignancies. Generated from their website's infomation

Cellaria is a unique establishment in Wakefield, MA that offers a variety of services catering to individuals seeking relaxation and rejuvenation. With a focus on wellness and self-care, Cellaria provides a tranquil environment for guests to unwind and experience a range of therapeutic treatments. Generated from their business information

Vor Biopharma Inc. is a clinical-stage biotechnology company based in Cambridge, MA, dedicated to transforming the treatment of autoimmune diseases. The company is advancing telitacicept, a novel dual-target recombinant fusion protein that targets key cytokines involved in B cell survival and autoantibody production, aiming to provide life-changing therapies for patients worldwide. With its leadership team, including CEO Jean-Paul Kress, M.D., and Chief Financial Officer Sandy Mahatme, Vor Bio is focused on the development and commercialization of innovative treatments. Telitacicept has already received approval in China for conditions such as generalized myasthenia gravis and systemic lupus erythematosus, and a global Phase 3 clinical trial is currently underway to support its approval in the United States and Europe. Generated from the website